Dottorato in Medicina Molecolare

1. Marano F, Rinella L, Argenziano M, Cavalli R, Sassi F, D’Amelio P, Battaglia A, Gontero P, Bosco O, Peluso R, Fortunati N, Frairia R, Catalano MG _ TARGETING TAXANES TO CASTRATION-RESISTANT PROSTATE CANCER CELLS BY NANOBUBBLES AND EXTRACORPOREAL SHOCK WAVES_ PlosONE 2016; 11(12):e0168553.
2. Marano F, Argenziano M, Frairia R, Adamini A, Bosco O, Rinella L, Fortunati N, Cavalli R, Catalano MG _ DOXORUBICIN-LOADED NANOBUBBLES COMBINED WITH EXTRACORPOREAL SHOCK WAVES: BASIS FOR A NEW DRUG DELIVERY TOOL IN ANAPLASTIC THYROID CANCER_ Thyroid. 26(5):705-16; 2016
3. Rinella L, Marano F, Berta L, Fraccalvieri M, Fortunati N, Frairia R, Catalano MG _ EXTRACORPOREAL SHOCK WAVES (ESWs) MODULATE ADIPOSE-DERIVED STEM CELL DIFFERENTIATION TOWARDS MYOFIBROBLASTS_ Wound Repair and Regeneration -2016 Jan 25. doi: 10.1111/wrr.12410. [Epub ahead of print]
4. Catalano MG, Marano F, Rinella L, de Girolamo L, Bosco O, Fortunati N, Berta L, Frairia R_ EXTRACORPOREAL SHOCKWAVES (ESWs) ENHANCE THE OSTEOGENIC MEDIUM-INDUCED DIFFERENTIATION OF ADIPOSE-DERIVED STEM CELLS INTO OSTEOBLAST-LIKE _ J Tissue Eng Regen Med. 2014 Jun 1. doi: 10.1002/term.1922
5. Fortunati N, Marano F, Bandino A, Frairia R, Catalano MG, Boccuzzi G_ THE PAN-HISTONE DEACETYLASE INHIBITOR LBH589 (PANOBINOSTAT) ALTERS THE INVASIVE BREAST CANCER CELL PHENOTYPE_ Int J Oncol. doi: 10.3892/ijo.2013.2218; 2013
6. Pugliese M, Fortunati N, Germano A, Asioli S, Marano F, Palestini N, Frairia R, Boccuzzi G, Catalano MG _HISTONE DEACETYLASE INHIBITION AFFECTS SODIUM IODIDE SYMPORTER EXPRESSION AND INDUCES ¹³¹I CYTOTOXICITY IN ANAPLASTIC THYROID CANCER CELLS_ Thyroid 23(7):838-46; 2013
7. Catalano MG, Fortunati N, Pugliese M, Marano F, Ortoleva L, Poli R, Asioli S, Bandino A, Palestini N, Grange C, Bussolati B, Boccuzzi G _HISTONE DEACETYLASE INHIBITION MODULATES E-CADHERIN EXPRESSION AND SUPPRESSES MIGRATION AND INVASION OF ANAPLASTIC THYROID CANCER CELLS_  J Clin Endocrinol Metab. 97(7):E1150-9; 2012
8. Fortunati N, Catalano MG, Marano F, Mugoni V, Pugliese M, Bosco O, Mainini F, Boccuzzi G _THE PAN-DAC INHIBITOR LBH589 IS A MULTI-FUNCTIONAL AGENT IN BREAST CANCER CELLS: CYTOTOXIC DRUG AND INDUCER OF SODIUM-IODIDE SYMPORTER (NIS)_ Breast Cancer Res Treat. 124 : 667-75; 2010 

 

1. Marano F, Argenziano M, Cavalli R, Bussolati B, Grange C, Cedrino M, Mastrocola R, Bosco O, Rinella L, Frairia R, Catalano MG_ USO COMBINATO DI ONDE D’URTO EXTRACORPOREE E NANOBOLLE CARICATE CON DOXORUBICINA PER LA TERAPIA DEI TUMORI AVANZATI DELLA TIROIDE_3° Congresso nazionale CLUB SIE Endocrinologia Oncologica, 2016, Turin.
2. Marano F, Zunino V, Frairia R,  Arvat E, Catalano MG, Fortunati N_ LA FIBULINA 1 (FBLN1) E LA SEX HORMONE BINDING GLOBULIN (SHBG) COOPERANO FUNZIONALMENTE NEI CARCINOMI MAMMARI ESTROGENO-DIPENDENTI_ 3° Congresso nazionale CLUB SIE Endocrinologia Oncologica, 2016, Turin.
3. Rinella L, Marano F, Peluso R, Argenziano M, Cavalli R, Bosco O, Fortunati N, Frairia R, Catalano MG_ NUOVE STRATEGIE PER IL TRATTAMENTO DEI TUMORI PROSTATICI ANDROGENO-INSENSIBILI: USO COMBINATO DI NANOBOLLE CARICATE CON TAXANI E ONDE D’URTO EXTRACORPOREE_ 3° Congresso nazionale CLUB SIE Endocrinologia Oncologica, 2016, Turin.
4. Marano F, Argenziano M, Frairia R, Bussolati B, Grange C, Cedrino M, Mastrocola R, Adamini A, Bosco O, Rinella L, Cavalli R, Catalano MG_DOXORUBICIN-LOADED NANOBUBBLES COMBINED WITH EXTRACORPOREAL SHOCK WAVES: BASIS FOR A NEW DRUG DELIVERY TOOL IN ANAPLASTIC THYROID CANCER_ D-DAY 2016, Molecular Biotechnology Center, 2016, Turin.
5. Argenziano M,  Marano F, Catalano MG, Frairia R, Cavalli R_NANOBUBBLES COMBINED WITH EXTRACORPOREAL SHOCK WAVES FOR ENHANCED TARGETED INTRACELLULAR DELIVERY OF DOXORUBICIN_ CRS 2015, Edimburgh; 2015
6. Frairia R, Marano F, Cavalli R, Catalano MG_EFFETTI ANTITUMORALI DEL TRATTAMENTO COMBINATO CON ESW E NANOBOLLE CARICATE CON DOXORUBICINA NEL CARCINOMA ANAPLASTICO DELLA TIROIDE_ XII National Congress S.I.T.O.D., Verona, 2014
7. Marano F, Catalano MG, Adamini A, Cavalli R, Argenziano M, Bosco O, Fortunati N, Frairia R_ COMBINATION OF EXTRACORPOREAL SHOCK WAVES (ESW) AND DOXORUBICIN-LOADED NANOBUBBLES: ANTI-TUMOR EFFECTS IN ANAPLASTIC THYROID CANCER_ Workshop SIC Targeted Therapy of Cancer: where we are heading, Abstract Book, Abstract OP4; 2014
8. Marano F, Catalano MG, Adamini A, Cavalli R, Bosco O, Fortunati N, Frairia R_ COMBINATION OF EXTRACORPOREAL SHOCK WAVES (ESW) AND DOXORUBICIN-LOADED NANOBUBBLES: ANTI-TUMOR EFFECTS IN ANAPLASTIC THYROID CANCER_17^th international Congress of the ISMST,Milano 2014
9. Marano F, Catalano MG, Cavalli R, Bosco O, Fortunati N, Frairia R _ ANTI-TUMOR EFFECTS OF COMBINING EXTRACORPOREAL SHOCK WAVES (ESW) AND DOXORUBICIN-LOADED NANOBUBBLES IN ANAPLASTIC THYROID CANCER _ 3^th ISMST Basic Research, Frankfurt am Main, Germany; 2014
10. Catalano MG, Marano F, Rinella L, Fraccalvieri M, Berta L, Frairia R _GENE EXPRESSION PROFILES IN HUMAN ADIPOSE DERIVED STEM CELLS AFTER EXTRACORPOREAL SHOCK WAVE TREATMENT: A PRELIMINARY STUDY­ _ 3^th ISMST Basic Research, Frankfurt am Main, Germany; 2014
11. Argenziano M, Cavalli R, Marano F, Catalano MG, Frairia R_DOXORUBICIN-LOADED NANOBUBBLES FOR COMBINIG SHOCK WAVES AND TARGETED CHEMOTHERAPY_CRS 2014, Firenze; 2014
12. Argenziano M, Cavalli R, Marano F, Rinella L, Catalano MG, Frairia R _ DOXORUBICIN-LOADED NANOBUBBLES AND SHOCK WAVES AS EFFECTIVE TOOL FOR TARGETED DELIVERY TO CANCER CELLS_ 9^th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Lisbon, Portugal; 2014
13. Catalano MG, Marano F, Rinella L, Bellonio C, Fortunati N, Berta L, Frairia R _EXTRACORPOREAL SHOCK WAVES (ESW) TRIGGER DRUG RELEASE AND ENHANCE CYTOTOXIC EFFECTS OF DOXORUBICIN-LOADED NANOBUBBLES IN ANAPLASTIC THYROID CANCER _ 16^th International Congress of the ISMST, Abstract Book, Abstract 26; 2013
14. Berta L, Frairia R, Catalano MG, Marano F, Rinella L, Meschieri S, Bosco O _REACTIVE OXYGEN SPECIES AND ERK PHOSPHORYLATION MEDIATE OSTEOBLAST DIFFERENTIATION OF HUMAN ADIPOSE DERIVED STEM CELLS (hASC) INDUCED BY EXTRACORPOREAL SHOCK WAVES _ 16^th International Congress of ISMST, Abstract Book, Abstract 6; 2013
15. Frairia R, Catalano MG, Canaparo R, Serpe L, Marano F, Berta L _EFFETTO DELLE ONDE D’URTO NEL POTENZIARE L’EFFETTO CITOSTATICO DI FARMACI ANTINEOPLASTICI_ XI National Congress S.I.T.O.D., Abstracts Book, pag. 34; 2012
16. Catalano MG, Marano F, Bosco O, Rinella L, Fortunati N, Boccuzzi G, Berta L, Frairia R _EFFETTO DELLE ONDE D’URTO SUL DIFFERENZIAMENTO DI CELLULE STAMINALI MESENCHIMALI IN CELLULE OSTEOPROGENITRICI_ XI National Congress S.I.T.O.D., Abstracts Book, pag. 32; 2012
17. Marano F, Catalano M, Frairia R, Boccuzzi G and Fortunati  N _LOOKING FOR THE MOLECULAR BRIDGE BETWEEN SEX HORMONE-BINDING GLOBULIN (SHBG) AND BREAST CANCER CELLS_ 15^th International & 14^th European Congress of Endocrinology (ICE\ECE 2012), Endocrine Abstracts Vol 29 P810; 2012
18. Frairia R, Catalano MG, Marano F, Bosco O, Berta L _EXTRACORPOREAL SHOCK WAVES MODULATE OSTEOGENIC DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS_ 2nd ISMST Basic Research Meeting, Innsbruck, Austria; 2012
19. Pugliese M, Fortunati N, Marano F, Poli R, Asioli S, Palestini N, Mainini F, Boccuzzi G, Catalano MG _THE DEACETYLASE INHIBITOR PANOBINOSTAT INHIBITS THE INVASIVE ACTIVITY OF ANAPLASTIC THYROID CANCER CELLS_  53nd Annual Meeting of Italian Cancer Society; Abstracts Book, pag. 40; 2011
20. Marano F, Catalano MG, Mainini F, Boccuzzi G, Fortunati N _THE pan-DAC INHIBITOR LBH589 INDUCES E-CADHERIN EXPRESSION IN ESTROGEN-RECEPTOR NEGATIVE BREAST CANCER  CELLS_ 53nd Annual Meeting of Italian Cancer Society; Abstracts Book, pag.48; 2011
21. Fortunati N,  Catalano MG, Marano F, Pugliese M, Mainini F, Boccuzzi G _THE pan-DAC INHIBITOR LBH589 INDUCES NIS (SODIUM-IODIDE SYMPORTER) EXPRESSION IN BREAST CANCER_  52nd Annual Meeting of Italian Cancer Society; Abstracts Book, pag.119; 2010.
22. Fortunati N, Catalano MG, Marano F, Pugliese M, Mugoni V, Mainini F, Boccuzzi G _ EFFECTS OF THE pan-DAC INHIBITOR LBH589 IN ESTROGEN SENSITIVE AND INSENSITIVE BREAST CANCER CELLS_ ASCO Annual Meeting, e13618, www.asco.org; 2010

ORAL PRESENTATIONS:

- Workshop SIC Targeted Therapy of Cancer: where we are heading, June 27 2014; Torino

- 17^th International Congress of the ISMST, June 26-28 2014; Milano

- 3^th ISMST Basic Research,  January 24-25 2014; Frankfurt am Main, Germany

- 16^th International Congress of ISMST, June 27-29 2013; Salzburg, Austria

 

ATTENDED CONGRESSES:

-Enabling technologies in 3D cancer oraganoids, March 8-9 2016; Torino

- Aspetti metodologici del therapeutic drug monitoring: dal laboratorio alla pratica clinica (2a edizione), Jenuary 19 2016; Torino

-2015 International Conference on Molecular Oncology "From Signal Transduction to Cancer Precisione Medicine", June 6-7 2015; Candiolo

-Frontiers in Regenerative Medicine, February 19-20 2015; Torino

-XXI Convegno annuale Associazione Italiana per le Scienze degli Animali da Laboratorio. I metodi alternativi e lo xenotrapianto nella ricerca biomedica: luci e ombre del DLgs 26/2014. Giornata di Studio: I Metodi Alternativi alla Sperimentazione Animale, October 23 2014; Grugliasco

-4th International Satellite Symposium, AICC-GISM. Mesenchymal Stromal Cells Advances, November 22 2013; Brescia

-XI Congresso Nazionale Società Italiana di Terapia con Onde d'Urto (SITOD), October 26 2012; Torino

ORAL PRESENTATIONS:

-Presentazione Lab. di Endocrinologia & Radiobiologia ed Endocrinologia Oncologica_  SHBG: effetti anti-estrogenici, organizzato dal  Dipartimento di Scienze Mediche,  December 5  2013; Torino

- Presentazione Lab. di Endocrinologia & Radiobiologia ed Endocrinologia Oncologica_ Effetto delle onde d'urto sul differenziamento di cellule staminali mesenchimali in cellule osteoprogenitrici, organizzato dal Dipartimento di Scienze Mediche, March 21 2013; Torino

 

ATTENDED SEMINARS:

-Nanomedicine for targeted drug delivery, organizzato dal Dottorato in Scienze Farmaceutiche e Biomolecolari, October 11 2016, Dip. di Scienza e tecnologia del farmaco; Torino

-Giornata di studio Guido Tarone, organizzato dal Dottorato in Scienze Biomediche e Oncologia & Dottorato in Medicina Molecolare,  May 24 2016, MBC; Torino

-Keynote seminars on cardiovascular research, organizzato da Emilio Hirsch & Tiziana Crepaldi, January 15 2016, MBC; Torino

-Isoforms of PI 3-kinase: from the bench to the clinic, organizzato dalla prof.ssa Valeria Poli e il prof. Emilio Hirsch, December 4 2015, MBC; Torino

-Stem Cells, expand your research network - GeneArt Engineered Cell Models collection, organizzato da Thermo Fisher Life Science, November 30 2015, MBC; Torino

-Good Pipetting Practice (GPP), organizzato da Mettler Toledo, November 18 2015, Dipartimento di Scienze Mediche; Torino

-Il futuro della medicina rigenerativa con cellule staminali (Adipose Derived Stem Cells), organizzato dalla SC di Chirurgia Plastica e Ricostruttiva, November 12 2015, Dipartimento Neuroscienze; Torino

-Translational models of human thyroid cancer harboring the oncogene BRAF^V600E, organizzato dal Dottorato in Medicina Molecolare, December 16 2014, MBC; Torino

-3D culture models and tissue-specific microenviroments: new frontiers for basic and applied research, organizzato dal Dottorato in Medicina e Terapia Sperimentale, September 30 2014; Dipartimento di Scienze Cliniche e Biologiche; Torino

-SINEUPs: a new functional class of antisense non-coding RNAs that activate translation, organizzato dal Dottorato in Scienze Biomediche e Oncologia, May 23 2013, Dipartimento di Scienze mediche; Torino

-Cracking the code of pluripotent stem cells, organizzato da HUGEF, May 8 2013, MBC; Torino

-Mesenchymal stem cells and delivery vehicle of porphyrin loaded nanoparticles: effective photoinduced in vitro killing of osteosarcoma, organizzato dal Dipartimento di Scienza e Tecnologia del Farmaco, March 20 2013; Dipartimento di Scienza e Tecnologia del Farmaco; Torino

-Tumor-stroma interplay: a tale of 3M (motility, metabolism and miRNAs), organizzato dal Dottorato in Medicina Molecolare, February 13 2013, Dipartimento di Anatomia, Farmacologia e Medicina Legale; Torino

-Th17 a autoimmunità, organizzato dal Dottorato in Medicina Molecolare, January 9 2013, CeRMS; Torino

 

-2016 D-Day, September 15, 2016 (poster oral presentation and discussion)

-Laboratorio di fundraising, January/ February 2016

-Scientific English, September 2013/Apr 2014

-Introduction to Bibliographic Research, September 2013

-Biostatistics, June 2013:

-2013 D-Day, June 11 2013